WEIGAO GROUP(01066): Shandong Weigao Blood Purification Products plans to issue shares as consideration for the acquisition of 100% equity of Weigao Purui.

WEIGAO GROUP (01066) announced that on October 17, 2025, the company, Weihai Shengxi Enterprise Management Consulting Center (Limited Partnership) (Weihai Shengxi), Weihai Ruiming Enterprise Management Consulting Partnership Enterprise (Limited Partnership) (Weihai Ruiming), and Shandong Weigao Blood Purification Products Co., Ltd. (Shandong Weigao Blood Purification Products) signed a non-binding letter of intent, pursuant to which Shandong Weigao Blood Purification Products will issue consideration shares to all Weigao PuRui shareholders to acquire 100% equity of Weigao PuRui. It is reported that Shandong Weigao Blood Purification Products is a company established in China, with its A shares listed on the Shanghai Stock Exchange (Securities Code: 603014.SH). The company is mainly engaged in the research, development, production, and sales of medical products for blood purification, including blood dialyzers, blood dialysis tubing sets, blood dialysis machines, and peritoneal dialysis solutions, focusing on the fields of blood dialysis and peritoneal dialysis, supplemented by the sales of dialysis accessories. As of the date of this announcement, Shandong Weigao Blood Purification Products is controlled by the company's controlling shareholder, Weigao Group Co., Ltd. The company also directly holds 23.53% of Shandong Weigao Blood Purification Products' shares. Weigao PuRui focuses on the research, development, production, and sales of pharmaceutical packaging materials such as pre-filled drug delivery systems and automatic safety drug delivery systems, dedicated to providing global biopharmaceutical companies with one-stop drug delivery solutions. As of the date of this announcement, Weigao PuRui is a non-wholly-owned subsidiary of the company, with the company, Weihai Shengxi, and Weihai Ruiming holding 94.0706%, 4.0215%, and 1.9078% of the shares, respectively. The Board of Directors believes that if the potential transaction is completed, Weigao PuRui and Shandong Weigao Blood Purification Products will generate synergies in their businesses, and the overall business scope of the group will be further expanded.